ZOLL Medical Corp. (ZOLL) Tops Q2 EPS by 7c

April 28, 2011 4:41 PM EDT
ZOLL Medical Corp. (NASDAQ: ZOLL) reported Q2 EPS of $0.27, $0.07 better than the analyst estimate of $0.20. Revenue for the quarter came in at $122.5 million versus the consensus estimate of $121.05 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings